Journal profile · Pathology
Fetal and Pediatric Pathology
ISSN 1551-3815 · eISSN 1551-3823 · Informa Healthcare · UNITED STATES · Bimonthly · Founded 2004
Fetal and Pediatric Pathology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.77; subscription journal; APC charged, amount not published; median 126 days to acceptance (91 articles, last 24 months); community-reported acceptance: easy; 51 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Fetal and Pediatric Pathology is published by Informa Healthcare and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Congenital Diaphragmatic Hernia Studies, Prenatal Screening and Diagnostics and Congenital Anomalies and Fetal Surgery, together about 22.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Fetal and Pediatric Pathology is an established bimonthly international journal that publishes data on diseases of the developing embryo, newborns, children, and adolescents. The journal publishes original and review articles and reportable case reports. The expanded scope of the journal encompasses molecular basis of genetic disorders; molecular basis of diseases that lead to implantation failures; molecular basis of abnormal placentation; placentology and molecular basis of habitual abortion; intrauterine development and molecular basis of embryonic death; pathogenisis and etiologic factors involved in sudden infant death syndrome; the underlying molecular basis, and pathogenesis of diseases that lead to morbidity and mortality in newborns; prenatal, perinatal, and pediatric diseases and molecular basis of diseases of childhood including solid tumors and tumors of the hematopoietic system; and experimental and molecular pathology.
From the journal's Aims & Scope
Research area (LetPub): Pathology
Editor-in-chief Mai (Mike) HePublisher website
Editorial board by country: none in mainland China; most named United States 28, Italy 2, Canada 2, Spain 1, Brazil 1 (35 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Congenital Diaphragmatic Hernia StudiesMedicine7.9%
- Prenatal Screening and DiagnosticsMedicine7.6%
- Congenital Anomalies and Fetal SurgeryMedicine7.1%
- Neonatal Respiratory Health ResearchMedicine7%
- Sarcoma Diagnosis and TreatmentMedicine6.9%
- Pregnancy and preeclampsia studiesMedicine6.6%
- Renal and related cancersBiochemistry, Genetics and Molecular Biology5.2%
- Urological Disorders and TreatmentsMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 4 |
| Minor | Pediatrics | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 4 |
| Minor | Pediatrics | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 4 |
| Minor | Pediatrics | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCurrent ContentsPublisher website
Other: ProQuest, OCLC, Adis International Ltd., EBSCOhost, Personal Alert (E-mail)
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.77LetPub ·
- Impact factor (publisher) 2025
- 0.8Publisher website ·
- 5-year impact factor (publisher) 2025
- 0.9Publisher website ·
- CiteScore 2026-06
- 1.9LetPub ·
- CiteScore (publisher) 2025
- 1.9Publisher website ·
- SJR 2026-06
- 0.36LetPub ·
- SJR (publisher) 2025
- 0.36Publisher website ·
- SNIP 2026-06
- 0.5LetPub ·
- SNIP (publisher) 2025
- 0.5Publisher website ·
- h-index
- 34LetPub ·
- h-index
- 45OpenAlex ·
- i10-index
- 477OpenAlex ·
- 2-year mean citedness
- 0.67OpenAlex ·
- Self-citation rate
- 12.5%LetPub ·
- Share of gold OA articles
- 3.9%LetPub ·
Volume
- Articles per year
- 52LetPub ·
- Articles per year (publisher)
- 3Publisher website ·
- Downloads per year (publisher)
- 46,000Publisher website ·
Articles by year OpenAlex count · 2,278 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 33 | 2 | 6 |
| 2025 | 51 | 6 | 30 |
| 2024 | 46 | 4 | 51 |
| 2023 | 63 | 9 | 163 |
| 2022 | 76 | 6 | 222 |
| 2021 | 47 | 2 | 220 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
126 daysMedian, submission to acceptance · P25–P75 75 days – 187 days
- Acceptance to online
- median 17 days (91 articles)
- Submission to online
- median 153 days
- Sample
- 91 articles with submission and acceptance dates (93 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 22%Publisher website ·
- Submission to first decision
- 7 daysPublisher website ·
- First decision after review
- 49 daysPublisher website ·
- Acceptance to publication
- 16 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open access
Fetal and Pediatric Pathology is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverabili…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Informa Healthcare
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2004
- ISSN
- 1551-3815
- Electronic ISSN
- 1551-3823
- Latest issue on the website
- Volume 45, Issue 2 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Fetal and Pediatric Pathology
What CAS zone is Fetal and Pediatric Pathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Fetal and Pediatric Pathology is in Zone 4 of Medicine, and in Zone 4 of the minor category Pathology / Pediatrics. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Fetal and Pediatric Pathology?
The latest impact factor listed by LetPub is 0.77; CiteScore 1.9, h-index 45.
How long does peer review take at Fetal and Pediatric Pathology?
Based on the dates recorded on 91 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 126 days (interquartile range 75–187 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 22%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Fetal and Pediatric Pathology based?
Of the 35 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (28), Italy (2) and Canada (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Fetal and Pediatric Pathology?
According to LetPub and DOAJ records, Fetal and Pediatric Pathology is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase and Current Contents; that list has not been checked against each database.
Is Fetal and Pediatric Pathology open access, and what is the APC?
Fetal and Pediatric Pathology is a subscription journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .